Download - WHOCC

Contents
1 Introduction to the ATCvet classification system ............................................ 11
1.1 History of the ATC/DDD- and the ATCvet systems................................... 11
1.2 The purpose of the ATCvet classification system ....................................... 11
1.3 Relationship between the ATCvet system and the ATC system for
medicines for human use ............................................................................. 12
1.4 The ATCvet classification systems.............................................................. 12
2. Classification principles...................................................................................... 13
2.1 General principles ........................................................................................ 13
2.2 Classification of plain preparations ............................................................. 16
2.3 Classification of combination products ....................................................... 16
3. Procedures and data requirements for ATCvet classifications and
alterations............................................................................................................. 17
3.1 Classification of new substances and data requirements ............................. 17
3.2 Principles regarding alterations to the ATCvet system................................ 18
3.3 Reporting...................................................................................................... 19
4. ATCvet Index....................................................................................................... 19
5. References ............................................................................................................ 19
6. ATCvet main groups........................................................................................... 21
QA - Alimentary tract and metabolism........................................................................ 21
This group comprises preparations used for the treatment of diseases
affecting the alimentary tract or metabolism, e.g. antacids and
antiemetics. It also includes e.g. antispasmodic and anticholinergic
agents, vitamins and drugs used in diabetes.
QB - Blood and blood forming organs ........................................................................ 39
The group QB comprises preparations mainly affecting the blood or the
blood forming organs. For example, it includes antithrombotic agents,
antianemic preparations and plasma substitutes.
QC - Cardiovascular system........................................................................................ 45
This group comprises preparations used in the treatment of diseases
affecting the cardiovascular system, or whose action is believed to be
mediated mainly via the cardiovascular system. Included are, for
example, antihypertensives and drugs for cardiac diseases.